Medicare Enrolled

Dr. Eduardo Garcia, MD

Hematology & Oncology · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3450 LANTANA RD, Lake Worth, FL 33462
5619651864
In practice since 2006 (19 years)
NPI: 1982611398 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garcia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garcia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garcia

Dr. Eduardo Garcia is a hematology & oncology in Lake Worth, FL, with 19 years in practice. Based on federal Medicare data, Dr. Garcia performed 110,071 Medicare services across 4,282 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garcia received a total of $8,511 from 56 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garcia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 6% volume in FL$ $8,511 industry payments

Medicare Practice Summary

Medicare Utilization ↗
110,071
Medicare services
Top 6% in FL for hematology & oncology
4,282
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,793 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)66,750$1$4
Darbepoetin injection (Aranesp) for anemia15,500$2$9
Epoetin alfa injection (Procrit) for anemia9,130$6$20
Denosumab injection (Prolia/Xgeva)2,160$19$31
Complete blood count (CBC) with differential1,601$8$24
Injection, heparin sodium, (heparin lock flush), per 10 units1,600$0$0
Blood draw (venipuncture)1,495$8$12
Comprehensive metabolic blood panel1,005$10$38
Lactate dehydrogenase (enzyme) level939$6$15
Office visit, established patient (30-39 min)884$96$150
Anti-nausea injection (ondansetron/Zofran)880$0$7
Dexamethasone injection (steroid)720$0$3
Uric acid level test704$4$10
Infusion, normal saline solution, 250 cc623$1$9
Ferritin level test (iron stores)620$13$47
Iron level test617$6$30
Transferrin (iron binding protein) level617$12$40
Red blood count, manual test597$4$18
Drug injection, under skin or into muscle574$11$45
Vitamin B-12 level test420$15$55
Red blood cell sedimentation rate, to detect inflammation, non-automated399$4$13
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional285$18$32
Carcinoembryonic antigen (cea) protein level236$19$65
Hospital follow-up visit, high complexity217$97$150
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less207$50$155
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less196$23$175
Initial hospital admission, high complexity145$139$280
Office visit, established patient, complex (40-54 min)122$141$200
Administration of chemotherapy into vein, each additional hour110$22$90
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3102$20$55
Administration of chemotherapy into vein, 1 hour or less93$103$270
Administration of additional new drug or substance into vein, 1 hour or less64$52$170
Folic acid level test63$14$32
Thyroid stimulating hormone (TSH) test57$16$32
Thyroid hormone evaluation52$6$12
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle52$56$125
Thyroxine (thyroid chemical), total51$7$13
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion50$16$65
New patient office visit, complex (60-74 min)47$172$300
PSA test (prostate cancer screening)40$18$69
Basic metabolic blood panel35$8$30
Flu vaccine administration12$32$35
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.6% high complexity
28.0% medium
10.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,511
Total received (2018-2024)
Avg $1,216/year across 7 years
Top 38% in FL for hematology & oncology
56
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,936 (58.0%)
Other
Charitable contributions, space rental, and other categories
$1,893 (22.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,682 (19.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,181
2023
$1,177
2022
$929
2021
$546
2020
$608
2019
$1,963
2018
$1,107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,104
Seattle Genetics, Inc.
$1,522
Janssen Biotech, Inc.
$559
Celgene Corporation
$340
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Incyte Corporation
$270
Genentech USA, Inc.
$248
PFIZER INC.
$233
Seagen Inc.
$206
Sirtex Medical Inc
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$170
E.R. Squibb & Sons, L.L.C.
$165
ABBVIE INC.
$155
Astellas Pharma US Inc
$146
GlaxoSmithKline, LLC.
$117
Takeda Pharmaceuticals U.S.A., Inc.
$115
Saluda Medical Americas, Inc.
$109
EMD Serono, Inc.
$104
GENZYME CORPORATION
$81
Daiichi Sankyo Inc.
$77
Eisai Inc.
$77
Kite Pharma, Inc.
$74
AstraZeneca Pharmaceuticals LP
$68
Pharmacyclics LLC, An AbbVie Company
$65
Dova Pharmaceuticals
$65
Pharmacyclics LLC, an AbbVie Company
$64
AbbVie, Inc.
$59
Bayer HealthCare Pharmaceuticals Inc.
$57
EISAI INC.
$49
Ipsen Biopharmaceuticals, Inc
$46
Merck Sharp & Dohme Corporation
$44
AVEO Pharmaceuticals, Inc.
$42
Karyopharm Therapeutics Inc.
$41
Lilly USA, LLC
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
ARRAY BIOPHARMA INC
$36
Global Blood Therapeutics, Inc.
$34
Intuitive Surgical, Inc.
$33
Janssen Pharmaceuticals, Inc
$29
Coherus Biosciences Inc.
$29
Amgen Inc.
$28
Exelixis Inc.
$27
Fennec Pharmaceuticals, Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
Adaptive Biotechnologies Corporation
$23
Merck Sharp & Dohme LLC
$22
Stemline Therapeutics Inc.
$20
APO-PHARMA USA, INC.
$19
Jazz Pharmaceuticals Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$18
Aveo Pharmaceuticals, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$15
Myovant Sciences Inc.
$14
Clovis Oncology, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 49.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · Alecensa · Aliqopa · BENDEKA · BOSULIF · BRAFTOVI · Bavencio · CARVYKTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Da Vinci Surgical System · Doptelet · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Evoke · FERRIPROX · FOTIVDA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · INFLECTRA · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUPRON DEPOT · LUTATHERA · Lenvima · MEKINIST · NINLARO · Nexavar · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Pomalyst · Prolia · REBLOZYL · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Somatuline Depot · TAGRISSO · TASIGNA · TECENTRIQ · Udenyca · VENCLEXTA · VOTRIENT · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $8 per 100 Medicare services performed
Looking for a hematology & oncology in Lake Worth?
Compare hematology & oncologys in the Lake Worth area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
40
Per 100K population
2.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garcia is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garcia experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Garcia performed 66,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garcia receive payments from pharmaceutical companies?
Yes. Dr. Garcia received a total of $8,511 from 56 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garcia's costs compare to other hematology & oncologys in Lake Worth?
Dr. Garcia's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garcia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →